Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
The traditional Japanese medicine Tokishakuyakusan (TSS) reduces the number and severity of endometriosis-like lesions in a mouse model, a new study shows. The research was published recently in the ... Read more
The application of Surgicel, a material used to help control bleeding, can reduce the chance of recurrence following surgery for ovarian endometriomas, a new study suggests. The study, titled ... Read more
A new study suggests that middle-aged people with surgically confirmed endometriosis have a slightly lower mortality rate than their peers who don’t have endometriosis. The reasons for this aren’t ... Read more
Orilissa (elagolix), a treatment that reduces pain in endometriosis, can also have economic benefits, a study reports. The therapy allowed patients to work more and be more productive, which ... Read more
The pharmaceutical companies Debiopharm and Ipsen have extended their agreement for the development, manufacturing, and distribution of Decapeptyl (triptorelin), used in the treatment of endometriosis. This partnership, which began ... Read more
The protein galectin-3 (Gal-3) might play a key role in the development of endometriosis, a study suggests. Moreover, blocking this protein may be a possible treatment strategy. The study, ... Read more